PUMA BIOTECHNOLOGY, INC. (PBYI)
Pharmaceutical Preparations
Latest Price
$9.25
TTM P/E
17.79
Normalized P/E
59.29
Div Yield
--
Book Value
2.72
P/B Ratio
3.40
Valuation metrics
adjust assumptions →EPS: $0.61
Book value / share: $2.59
Formula: √(22.5 × EPS × BVPS)
Graham Number
$5.96
36% downside
Norm. op. income: $24M (median of 7yr)
Tax rate: 9%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$5.77
38% downside
Base FCF: $33M (median of recent 5yr)
Growth: 16%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$26.99
+192% upside
EPS: $0.61
Target P/E: 59×
Formula: EPS × P/E
P/E Fair Value
$35.99
+289% upside
Institutional Ownership
70.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | 4.13M | $33.0M | 8.08% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.80M | $30.0M | 7.45% | +205.8K | 2026-06-30 |
| AMERICAN CENTURY COMPANIES INC | 2.32M | $18.0M | 4.54% | +403.6K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.84M | $14.0M | 3.59% | -106.2K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.84M | $14.0M | 3.59% | +18.0K | 2026-06-30 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.83M | $14.0M | 3.57% | +91.0K | 2026-06-30 |
| LSV ASSET MANAGEMENT | 1.62M | $13.0M | 3.17% | +435.1K | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 1.52M | $12.0M | 2.97% | +81.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.34M | $10.0M | 2.62% | +322.1K | 2026-06-30 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 1.12M | $9.0M | 2.20% | -14.4K | 2026-06-30 |